clinical trial · NCT06666491
An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older
GlaxoSmithKline·phase3·recruiting·n = 300
Malaria, VivaxTafenoquinePrimaquineChloroquine
brief summary
The aim of this study is to collect efficacy and safety data to support the registration of tafenoquine in India.
started
Nov 13, 2024
primary completion
May 25, 2026
completion
May 25, 2026
last updated
Aug 7, 2025
official title
A Randomized, Open-label, Multi-center, Interventional Phase 3 Study of the Efficacy and. Safety of Tafenoquine Compared to Primaquine (Both Co-administered With Chloroquine) for the Radical Cure (Relapse Prevention) of Plasmodium Vivax (P. Vivax) Malaria in Indian Participants (Pediatric and Adult Population)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol